Sujal M. Patel
CEO, President, and Secretary at Nautilus Biotechnology Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Nautilus Biotechnology Inc., 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 | Nautilus Biotechnology Inc. | Open-market purchase | +25,000 | $2.61 | $65,250 |
| Sep 8, 2025 | Nautilus Biotechnology Inc. | Open-market purchase | +83,500 | $0.68 | $56,780 |
| Sep 5, 2025 | Nautilus Biotechnology Inc. | Open-market purchase | +116,500 | $0.67 | $78,055 |
| Mar 20, 2025 | Nautilus Biotechnology Inc. | Open-market purchase | +23,933 | $1.00 | $23,933 |
| Mar 19, 2025 | Nautilus Biotechnology Inc. | Open-market purchase | +53,300 | $0.99 | $52,767 |
| Mar 11, 2024 | Nautilus Biotechnology Inc. | Open-market purchase | +12,044 | $2.84 | $34,205 |
| Mar 8, 2024 | Nautilus Biotechnology Inc. | Open-market purchase | +2,430 | $2.99 | $7,266 |
| Mar 7, 2024 | Nautilus Biotechnology Inc. | Open-market purchase | +18,854 | $2.89 | $54,488 |
| Mar 6, 2024 | Nautilus Biotechnology Inc. | Open-market purchase | +9,267 | $2.70 | $25,021 |
| Mar 5, 2024 | Nautilus Biotechnology Inc. | Open-market purchase | +7,405 | $2.65 | $19,623 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.